trending Market Intelligence /marketintelligence/en/news-insights/trending/ba0r1nve-n1w-aqgvrqjyq2 content esgSubNav
In This List

Biostage closes $1M private placement

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Biostage closes $1M private placement

Biostage Inc. closed a private placement of 302,115 common shares to raise $1 million in gross proceeds.

The stocks were sold at $3.31 apiece to Jinhui Liu.

Holliston, Mass.-based Biostage is developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea.